Search Results - "O'KANE, Cecilia M"
-
1
Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management
Published in The Lancet (British edition) (01-10-2022)“…Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic respiratory failure with bilateral infiltrates on chest imaging, which is not…”
Get full text
Journal Article -
2
Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer
Published in American journal of respiratory and critical care medicine (15-11-2017)“…Acute respiratory distress syndrome (ARDS) remains a major cause of respiratory failure in critically ill patients. Mesenchymal stromal cells (MSCs) are a…”
Get full text
Journal Article -
3
Mesenchymal Stromal Cells in Acute Respiratory Distress Syndrome: More Questions Than Answers
Published in American journal of respiratory and critical care medicine (15-12-2023)“…Millar and O'Kane discuss the study by Batchinsky et al which uses a porcine model of smoke inhalation injury to compare the therapeutic efficacy of autologous…”
Get full text
Journal Article -
4
Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome
Published in American journal of respiratory and critical care medicine (01-02-2023)“…O'Kane and Matthay discuss the study by M. E. Bowdish and colleagues on bone marrow-derived mesenchymal stromal cells (MSCs) for the treatment of moderate to…”
Get full text
Journal Article -
5
Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS
Published in Stem cells (Dayton, Ohio) (01-08-2016)“…Mesenchymal stromal cells (MSC) have been reported to improve bacterial clearance in preclinical models of Acute Respiratory Distress Syndrome (ARDS) and…”
Get full text
Journal Article -
6
Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
Published in American journal of respiratory and critical care medicine (01-04-2024)“…There is considerable interest in the potential for cell-based therapies, particularly mesenchymal stromal cells (MSCs) and their products, as a therapy for…”
Get full text
Journal Article -
7
Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury
Published in Thorax (01-08-2018)“…Tumour necrosis factor alpha (TNF-α) is a pleiotropic cytokine with both injurious and protective functions, which are thought to diverge at the level of its…”
Get more information
Journal Article -
8
Simvastatin in the Acute Respiratory Distress Syndrome
Published in The New England journal of medicine (30-10-2014)“…In this study, patients with acute respiratory distress syndrome who were not receiving statins were assigned to receive simvastatin or placebo. At 28 days,…”
Get full text
Journal Article -
9
Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial
Published in Critical care (London, England) (07-06-2022)“…Interleukin (IL)-18 is a marker of inflammasome activation, and high baseline plasma IL-18 is associated with increased mortality in patients with…”
Get full text
Journal Article -
10
Where next for cell-based therapy in ARDS
Published in Thorax (01-01-2019)Get more information
Journal Article -
11
Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials
Published in Critical care (London, England) (28-03-2023)“…Two acute respiratory distress syndrome (ARDS) trials showed no benefit for statin therapy, though secondary analyses suggest inflammatory subphenotypes may…”
Get full text
Journal Article -
12
Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome
Published in American journal of respiratory and critical care medicine (15-02-2016)“…IL-17A is purported to help drive early pathogenesis in acute respiratory distress syndrome (ARDS) by enhancing neutrophil recruitment. Although IL-17A is the…”
Get full text
Journal Article -
13
Emerging drugs for treating the acute respiratory distress syndrome
Published in Expert opinion on emerging drugs (02-01-2019)“…The acute respiratory distress syndrome (ARDS) is a common and catastrophic condition, with a high mortality rate and economic burden on society. Despite…”
Get more information
Journal Article -
14
Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis
Published in Critical care (London, England) (23-03-2015)“…Acute respiratory distress syndrome (ARDS) is a common clinical syndrome with high mortality and long-term morbidity. To date there is no effective…”
Get full text
Journal Article -
15
Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation
Published in Science translational medicine (02-09-2015)“…Sepsis is the most frequent cause of death in hospitalized patients, and severe sepsis is a leading contributory factor to acute respiratory distress syndrome…”
Get more information
Journal Article -
16
Human mesenchymal stromal cells inhibit Mycobacterium avium replication in clinically relevant models of lung infection
Published in Thorax (01-08-2024)“…Novel therapeutic strategies are urgently needed for complex pulmonary disease (MAC-PD). Human mesenchymal stromal cells (MSCs) can directly inhibit MAC…”
Get more information
Journal Article -
17
TRPV2 modulates mechanically Induced ATP Release from Human bronchial epithelial cells
Published in Respiratory research (27-04-2024)“…Repetitive bouts of coughing expose the large airways to significant cycles of shear stress. This leads to the release of alarmins and the tussive agent…”
Get full text
Journal Article -
18
Keratinocyte Growth Factor Promotes Epithelial Survival and Resolution in a Human Model of Lung Injury
Published in American journal of respiratory and critical care medicine (15-06-2014)“…Increasing epithelial repair and regeneration may hasten resolution of lung injury in patients with the acute respiratory distress syndrome (ARDS). In animal…”
Get full text
Journal Article -
19
Cathepsin S Contributes to Lung Inflammation in Acute Respiratory Distress Syndrome
Published in American journal of respiratory and critical care medicine (01-04-2022)“…Although the cysteine protease cathepsin S has been implicated in the pathogenesis of several inflammatory lung diseases, its role has not been examined in the…”
Get full text
Journal Article -
20
Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials
Published in Critical care medicine (01-12-2023)“…Interleukin-18 (IL-18) plasma level and latent class analysis (LCA) have separately been shown to predict prognosis and treatment response in acute respiratory…”
Get full text
Journal Article